{"DataElement":{"publicId":"14674973","version":"1","preferredName":"Patient Cancer Therapeutic Procedure Clinical Trial Eligibility Criteria Type","preferredDefinition":"The type of cancer therapeutic procedure to determine clinical trial eligibility for a patient.","longName":"PT_CA_THRP_CTEC_TP","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"14674963","version":"1","preferredName":"Patient Cancer Therapeutic Procedure Clinical Trial Eligibility Criteria","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.:Any intervention for management of a malignant neoplasm._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"2233604v1.00:14418359v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14418359","version":"1","preferredName":"Cancer Therapeutic Procedure Clinical Trial Eligibility Criteria","preferredDefinition":"Any intervention for management of a malignant neoplasm._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C16212:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Therapeutic Procedure","conceptCode":"C16212","definition":"Any intervention for management of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"030FC825-8F0A-51A5-E063-731AD00A98C4","latestVersionIndicator":"Yes","beginDate":"2023-08-16","endDate":null,"createdBy":"GDEEN","dateCreated":"2023-08-16","modifiedBy":"GDEEN","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0E89EB5A-5C29-1893-E063-731AD00ACF18","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14674964","version":"1","preferredName":"Cancer Therapeutic Procedure Type","preferredDefinition":"Any intervention for management of a malignant neoplasm._Something distinguishable as an identifiable class based on common qualities.","longName":"14674964v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"300","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Patients initially recognized to have high-risk disease treated with topotecan/cyclophosphamide initiated on an emergent basis and within allowed timing, and with consent as described in Section 3.1.5","valueDescription":null,"ValueMeaning":{"publicId":"14674965","version":"1","preferredName":"Patients initially recognized to have high-risk disease treated with topotecan/cyclophosphamide initiated on an emergent basis and within allowed timing, and with consent as described in Section 3.1.5","longName":"14674965v1.00","preferredDefinition":"Patients initially recognized to have high-risk disease treated with topotecan/cyclophosphamide initiated on an emergent basis and within allowed timing, and with consent as described in Section 3.1.5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E8A3BF5-0CE0-2A0D-E063-731AD00A3AED","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E8A3BF5-0CE3-2A0D-E063-731AD00A3AED","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","deletedIndicator":"No"},{"value":"Patients observed or treated with a single cycle of chemotherapy per a low or intermediate risk neuroblastoma regimen for what initially appeared to be non-high-risk disease but subsequently found to meet the criteria in Section 3.2.3","valueDescription":null,"ValueMeaning":{"publicId":"14674966","version":"1","preferredName":"Patients observed or treated with a single cycle of chemotherapy per a low or intermediate risk neuroblastoma regimen for what initially appeared to be non-high-risk disease but subsequently found to meet the criteria in Section 3.2.3","longName":"14674966v1.00","preferredDefinition":"Patients observed or treated with a single cycle of chemotherapy per a low or intermediate risk neuroblastoma regimen for what initially appeared to be non-high-risk disease but subsequently found to meet the criteria in Section 3.2.3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E8A3BF5-0CE1-2A0D-E063-731AD00A3AED","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E8A3BF5-0CE4-2A0D-E063-731AD00A3AED","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","deletedIndicator":"No"},{"value":"Patients who received localized emergency radiation to sites of life-threatening or function-threatening disease prior to or immediately after establishment of the definitive diagnosis","valueDescription":null,"ValueMeaning":{"publicId":"14674967","version":"1","preferredName":"Patients who received localized emergency radiation to sites of life-threatening or function-threatening disease prior to or immediately after establishment of the definitive diagnosis","longName":"14674967v1.00","preferredDefinition":"Patients who received localized emergency radiation to sites of life-threatening or function-threatening disease prior to or immediately after establishment of the definitive diagnosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E8A3BF5-0CE2-2A0D-E063-731AD00A3AED","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E8A3BF5-0CE5-2A0D-E063-731AD00A3AED","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","deletedIndicator":"No"},{"value":"Other prior therapy","valueDescription":null,"ValueMeaning":{"publicId":"14674968","version":"1","preferredName":"Other Prior Cancer Therapeutic Procedure","longName":"14674968v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned._Earlier in time or order._Any intervention for management of a malignant neoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cancer Therapeutic Procedure","conceptCode":"C16212","definition":"Any intervention for management of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E8A4D28-0203-2CE7-E063-731AD00AE752","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E8A4D28-0204-2CE7-E063-731AD00AE752","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3282848","version":"1","preferredName":"Cancer Treatment Type","preferredDefinition":"Any intervention for management of a malignant neoplasm.:Type; a subdivision of a particular kind of thing.","longName":"C16212:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer Therapeutic Procedure","conceptCode":"C16212","definition":"Any intervention for management of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AD89FB60-A11F-4AC0-E040-BB89AD4312AF","latestVersionIndicator":"Yes","beginDate":"2011-09-22","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-09-22","modifiedBy":"ONEDATA","dateModified":"2011-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0E8A0D21-F886-1F76-E063-731AD00ABC81","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"ANTI_TX_TYPE","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the type of cancer therapeutic procedure to determine clinical trial eligibility?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Type of anti-cancer therapy:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"0E8ACFD9-2A9E-4FB5-E063-731AD00AB6AE","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-09","modifiedBy":"KUMMEROA","dateModified":"2024-01-09","changeDescription":null,"administrativeNotes":"2024.1.9 Created per ticket request CADSR0003241. ak","unresolvedIssues":null,"deletedIndicator":"No"}}